Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 205 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 01/30/18
End: 12/14/19
Due: 12/14/20
Phase: N/A
Priority: Normal
Start: 09/01/17
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 06/20/22
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 10/20/19
End: 12/30/21
Due: 12/30/22
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 08/19/24
End: 08/18/28
Due: 08/18/29
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 12/30/24
Due: 12/30/25
Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 01/04/20
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 06/01/19
End: 06/01/22
Due: 06/01/23
Phase: N/A
Priority: Normal
Start: 07/08/20
End: 12/12/21
Due: 12/12/22
Phase: N/A
Priority: Normal
Start: 06/30/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/01/17
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 06/01/22
Due: 06/01/23
Phase: N/A
Priority: Normal
Start: 04/27/21
End: 05/31/22
Due: 05/31/23
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 03/30/19
Due: 03/30/20